• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$38.61 -$0.08 (-0.21%)

REAL-TIME: Last trade at

Teva Pharmaceutical Industries

NASDAQ:TEVA

Jump to this page for:

Related Resources

Senate passes FDA funding bill, Reuters reports

5/25/2012 by Theflyonthewall.com

Teva price target lowered to $52 from $60 at UBS

5/25/2012 by Theflyonthewall.com

Teva valuation compelling despite reduced guidance, says Wells Fargo

5/24/2012 by Theflyonthewall.com

Teva breaks downtrend, tops 10-day MA, resistance now at $40.46

5/24/2012 by Theflyonthewall.com

Teva volatility elevated into 2012 sales guidance of $20B-$21B

5/24/2012 by Theflyonthewall.com

Teva says will look at divesting assets that "don't fit"

5/24/2012 by Theflyonthewall.com

Teva sees FY generic product net sales approximately $10.7B

5/24/2012 by Theflyonthewall.com

Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40

5/24/2012 by Business Wire

Teva says committed to transparency

5/24/2012 by Theflyonthewall.com

Teva previously forecast FY12 EPS $5.48-$5.68

5/24/2012 by Theflyonthewall.com

Teva says creating global compliance organization

5/24/2012 by Theflyonthewall.com

Teva sees Copaxone sales of $3.8B this year

5/24/2012 by Theflyonthewall.com

Teva says taking "hard look" at all of its assets

5/24/2012 by Theflyonthewall.com

Teva says regulatory measures in Europe adversely affecting revenues

5/24/2012 by Theflyonthewall.com

Teva says sees FY12 EPS $5.30-$5.40, consensus $5.59

5/24/2012 by Theflyonthewall.com

Viacom to replace Teva in NASDAQ-100 Index

5/24/2012 by Theflyonthewall.com

Teva to host business news update conference call

5/24/2012 by Theflyonthewall.com

Teva to Host Conference Call and Webcast on May 24, 2012

5/23/2012 by Business Wire

BioLineRx CFO says approached about schizophrenia pill, Bloomberg reports

5/23/2012 by Theflyonthewall.com

Teva initiated with a Hold at Auriga

5/23/2012 by Theflyonthewall.com

FTC, Senate probing blocking of generic drug companies, Washington Post says

5/23/2012 by Theflyonthewall.com

15 Most Oversold Nasdaq 100 Stocks

5/22/2012 by MoneyShow.com

Spread Trader Targets a Rebound in Teva Pharmaceutical

5/21/2012 by Schaeffer's Daily Market Blog

Spread Trader Targets a Rebound in Teva Pharmaceutical

5/21/2012 by Schaeffer's Investment Research

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan

5/21/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan - Press Releases

5/21/2012 by Zacks Investment Research

Generic Versions of Plavix Get FDA Approval

5/18/2012 by InvestorPlace

Teva’s Board of Directors Votes to Re-Elect Dr. Phillip Frost as Chairman of the Board

5/17/2012 by Business Wire

Teva, Ambit Biosciences announce clearance of IND app for CEP-32496

5/17/2012 by Theflyonthewall.com

Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor

5/17/2012 by PR Newswire

Aceto Looking At A Tough Future (ACET, TEVA, DOW, DD)

5/16/2012 by Investopedia

Analyst Research on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Mixed Results for Drug Manufacturers

5/16/2012 by StockHouse

Analyst Research on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Mixed Results for Drug Manufacturers

5/16/2012 by StockWatch

24/7 Wall St. Closing Bell (ORCL, NOV, MMM, TEVA, JDSU, AMCX, MT, HNR, KSS, WIN, DDS, JKS, PGR, SOL, URRE, MNST, WFR)

5/10/2012 by 24/7 Wall Street

Top Analyst Upgrades & Downgrades (ARMH, BIG, CHKM, CSCO, CPWM, DLB, HGSI, JDSU, LINE, MMM, NOV, ORCL, RGP, TPX, TLLP, TEVA, VRTX)

5/10/2012 by 24/7 Wall Street

Teva downgraded to Hold from Strong Buy at Needham

5/10/2012 by Theflyonthewall.com

Teva Pharmaceutical Industries Limited's CEO Discusses Q1 2012 Results - Earnings Call Transcript

5/9/2012 by Seeking Alpha

Teva results disappointing but positive catalysts remain, says Wells Fargo

5/9/2012 by Theflyonthewall.com

Teva Stock Slides After Mixed Q1; Outlook Unclear

5/9/2012 by Investor's Business Daily

Teva Pharmaceutical 1st-quarter profit climbs 13 per cent, helped by US sales growth

5/9/2012 by Canadian Business - Canada
See More Articles...